SCOPUS 정보 검색 플랫폼

Volumn 106, Issue 9, 2010, Pages 1277-1283

Usefulness of vernakalant hydrochloride injection for rapid conversion of atrial fibrillation

(8) Pratt, Craig M a Roy, Denis b Torp Pedersen, Christian c Wyse, D George d Toft, Egon e Juul Moller, Steen f Retyk, Enrique g Drenning, David Humphrey h

a HOUSTON METHODIST RESEARCH INSTITUTE (United States)

b MONTREAL HEART INSTITUTE (Canada)

c GENTOFTE UNIVERSITY HOSPITAL (Denmark)

d LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA (Canada)

e AALBORG UNIVERSITY (Denmark)

f LUND UNIVERSITY HOSPITAL (Sweden)

g Hospital Eva Peron (Argentina)

h PC (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; VERNAKALANT;

ADULT; AGED; AORTA STENOSIS; ARTICLE; BRADYCARDIA; CARDIAC PATIENT; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG FATALITY; DRUG SAFETY; DRUG TOLERABILITY; DYSGEUSIA; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART RATE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERHIDROSIS; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; NAUSEA; PARESTHESIA; PRIORITY JOURNAL; QRS COMPLEX; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINUS RHYTHM; SNEEZING; TORSADE DES POINTES;

ANISOLES; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PLACEBOS; PROSPECTIVE STUDIES; PYRROLIDINES; TREATMENT OUTCOME;

EID: 77958570420 PISSN: 00029149 EISSN: None Source Type: Journal
DOI: 10.1016/j.amjcard.2010.06.054 Document Type: Article

Times cited : (110)

References (7)

1
- 33644810948
- The mechanism of atrial antiarrhythmic action of RSD1235
- D. Fedida, P.M. Orth, J.Y. Chen, S. Lin, B. Plouvier, G. Jung, A.M. Ezrin, and G.N. Beatch The mechanism of atrial antiarrhythmic action of RSD1235 J Cardiovasc Electrophysiol 16 2005 1227 1238
- (2005) J Cardiovasc Electrophysiol , vol.16 , pp. 1227-1238
- Fedida, D.¹ Orth, P.M.² Chen, J.Y.³ Lin, S.⁴ Plouvier, B.⁵ Jung, G.⁶ Ezrin, A.M.⁷ Beatch, G.N.⁸

2
- 10644240535
- RSD1235 selectively prolongs atrial refractoriness and terminates AF in dogs with electrically remodelled atria
- G.N. Beatch, K. Shinagawa, B.D. Johnson, G. Jung, B. Plouvier, A. Zolotoy, A.M. Ezrin, M.J.A. Walker, and S. Nattel RSD1235 selectively prolongs atrial refractoriness and terminates AF in dogs with electrically remodelled atria Pacing Clin Electrophysiol 25 2002 698
- (2002) Pacing Clin Electrophysiol , vol.25 , pp. 698
- Beatch, G.N.¹ Shinagawa, K.² Johnson, B.D.³ Jung, G.⁴ Plouvier, B.⁵ Zolotoy, A.⁶ Ezrin, A.M.⁷ Walker, M.J.A.⁸ Nattel, S.⁹

3
- 34547666917
- The effect of vernakalant (RSD1235), an investigational antiarrhythmic agent, on atrial electrophysiology in humans
- P. Dorian, A. Pinter, I. Mangat, V. Korley, S.S. Cvitkovic, and G.N. Beatch The effect of vernakalant (RSD1235), an investigational antiarrhythmic agent, on atrial electrophysiology in humans J Cardiovasc Pharmacol 50 2007 35 40
- (2007) J Cardiovasc Pharmacol , vol.50 , pp. 35-40
- Dorian, P.¹ Pinter, A.² Mangat, I.³ Korley, V.⁴ Cvitkovic, S.S.⁵ Beatch, G.N.⁶

4
- 10644250949
- A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation
- Craft Investigators G.N.
- D. Roy, B.H. Rowe, I.G. Stiell, B. Coutu, J.H. Ip, D. Phaneuf, J. Lee, H. Vidaillet, G. Dickinson, S. Grant, A.M. Ezrin, G.N. Beatch Craft Investigators A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation J Am Coll Cardiol 44 2004 2355 2361
- (2004) J Am Coll Cardiol , vol.44 , pp. 2355-2361
- Roy, D.¹ Rowe, B.H.² Stiell, I.G.³ Coutu, B.⁴ Ip, J.H.⁵ Phaneuf, D.⁶ Lee, J.⁷ Vidaillet, H.⁸ Dickinson, G.⁹ Grant, S.¹⁰ Ezrin, A.M.¹¹ Beatch, G.N.¹²

5
- 41149179489
- Vernakalant hydrochloride for rapid conversion of atrial fibrillation: A phase 3, randomized, placebo-controlled trial
- Atrial Arrhythmia Conversion Trial Investigators A.J.
- D. Roy, C.M. Pratt, C. Torp-Pedersen, D.G. Wyse, E. Toft, S. Juul-Moller, T. Nielsen, S.L. Rasmussen, I.G. Stiell, B. Coutu, J.H. Ip, E.L. Pritchett, A.J. Camm Atrial Arrhythmia Conversion Trial Investigators Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial Circulation 117 2008 1518 1525
- (2008) Circulation , vol.117 , pp. 1518-1525
- Roy, D.¹ Pratt, C.M.² Torp-Pedersen, C.³ Wyse, D.G.⁴ Toft, E.⁵ Juul-Moller, S.⁶ Nielsen, T.⁷ Rasmussen, S.L.⁸ Stiell, I.G.⁹ Coutu, B.¹⁰ Ip, J.H.¹¹ Pritchett, E.L.¹² Camm, A.J.¹³

6
- 9444256916
- Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and flutter: A dose response study
- K.A. Ellenbogen, B.S. Stambler, M.A. Wood, P.T. Sager, R.C. Wesley Jr, M.C. Meissner, R.G. Zoble, L.K. Wakefield, K.T. Perry, and J.T. Vanderlugt Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and flutter: a dose response study J Am Coll Cardiol 28 1996 130 136
- (1996) J Am Coll Cardiol , vol.28 , pp. 130-136
- Ellenbogen, K.A.¹ Stambler, B.S.² Wood, M.A.³ Sager, P.T.⁴ Wesley Jr., R.C.⁵ Meissner, M.C.⁶ Zoble, R.G.⁷ Wakefield, L.K.⁸ Perry, K.T.⁹ Vanderlugt, J.T.¹⁰

7
- 0029778315
- Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation
- B.S. Stambler, M.A. Wood, K.A. Ellenbogen, K.T. Perry, L.K. Wakefield, and J.T. VanderLugt Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation Circulation 94 1996 1613 1621
- (1996) Circulation , vol.94 , pp. 1613-1621
- Stambler, B.S.¹ Wood, M.A.² Ellenbogen, K.A.³ Perry, K.T.⁴ Wakefield, L.K.⁵ Vanderlugt, J.T.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.